Tenere Capital’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.37M Sell
3,642
-2,948
-45% -$3.01M 3.47% 15
2026
Q1
$6.06M Buy
6,590
+3,958
+150% +$4.01M 4.44% 9
2025
Q4
$2.83M Buy
+2,632
New +$2.52M 2.19% 20

Other funds holding LLY

Tenere Capital's LLY Position: Q2 2026 in Review

Tenere Capital reduced its Eli Lilly (LLY) stake by 45% in Q2 2026, selling an estimated $3.01M and leaving 3,642 shares worth $4.37M. The position accounts for 3.47% of the portfolio, ranked #15.

Tenere Capital first reported a position in LLY in Q4 2025 and has held it in 3 quarters since. The position peaked at $6.06M in Q1 2026. 4,602 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Tenere Capital held 3,642 shares of Eli Lilly worth $4.37M as of Q2 2026.
  • Tenere Capital sold 2,948 Eli Lilly shares in Q2 2026, an estimated $3.01M.
  • Eli Lilly made up 3.47% of Tenere Capital's portfolio in Q2 2026, its #15 holding.
  • Tenere Capital first reported a position in Eli Lilly in Q4 2025 and has held it in 3 quarters since.
  • Tenere Capital's Eli Lilly position peaked at $6.06M in Q1 2026.
  • 4,602 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Tenere Capital's 13F filing for Q2 2026, filed 14 Aug 2026.